Improvement of blepharospasm with Zolpidem

被引：17

作者：

Garretto, NS ^{[1
]}

Bueri, JA ^{[1
]}

Rey, RD ^{[1
]}

Arakaki, T ^{[1
]}

Nano, GV ^{[1
]}

Mancuso, M ^{[1
]}

机构：

[1] Hosp JM Ramos Mejia, Dept Neurol, Movement Disorders Clin, RA-1221 Buenos Aires, DF, Argentina

来源：

MOVEMENT DISORDERS | 2004年 / 19卷 / 08期

关键词：

dystonia; blepharospasm; Zolpidem;

D O I：

10.1002/mds.20085

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Zolpidem (ZLP) is an imidazopyridine that binds to GABA receptors. We report on improvement of blepharospasm in 3 patients treated with ZLP. The GABAergic action of this drug on the output structures of the basal ganglia could explain the improvement of blepharospasm in these patients. (C) 2004 Movement Disorder Society.

引用

页码：967 / 968

页数：2

共 11 条

[1] The pathophysiology of primary dystonia [J].

Berardelli, A ;

Rothwell, JC ;

Hallett, M ;

Thompson, PD ;

Manfredi, M ;

Marsden, CD .

BRAIN, 1998, 121 :1195-1212

[2] Zolpidem in Parkinson's disease [J].

Daniele, A ;

Albanese, A ;

Gainotti, G ;

Gregori, B ;

Bartolomeo, P .

LANCET, 1997, 349 (9060) :1222-1223

[3] Zolpidem in progressive supranuclear palsy [J].

Daniele, A ;

Moro, E ;

Bentivoglio, AR .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :543-544

[4] Zolpidem improves dystonia in "Lubag" or X-linked dystonia-parkinsonism syndrome [J].

Evidente, VGH .

NEUROLOGY, 2002, 58 (04) :662-663

[5]

Farver DK, 2001, ANN PHARMACOTHER, V35, P435

[6] Zolpidem - An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia [J].

Holm, KJ ;

Goa, KL .

DRUGS, 2000, 59 (04) :865-889

[7]

MASTAIN B, 1995, REV NEUROL, V151, P52

[8]

Ruzicka E, 2000, MOVEMENT DISORD, V15, P734, DOI 10.1002/1531-8257(200007)15:4<734::AID-MDS1022>3.0.CO

[9]

2-E

[10]

Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO

← 1 2 →